Online Program Home
  My Program

All Times EDT

Legend:
* = applied session       ! = JSM meeting theme

Activity Details


220184
Sun, 8/2/2020, 5:00 PM - 6:30 PM Virtual
Section of Statistical Programmers and Analysts Executive Officers Meeting — Other Cmte/Business
Section for Statistical Programmers and Analysts
Chair(s): Vipin Arora, Eli Lilly and Company
SSPA Executive Officers Meeting - by Invitation only!
Email contacts: vipin.arora@gmail.com (Chair); hakhunavneet@gmail.com (Program Chair); Tasneem Zaihra, zaihra@brockport.edu (Publication Officer) ; Tessa: ychen4@udayton.edu (Secretary); Gerald: gerald.belton@gmail.com (Treasurer)
 
 

22 * !
Mon, 8/3/2020, 10:00 AM - 11:50 AM Virtual
Design and Evaluation of Adaptive Design Clinical Trials: Software Demonstration — Invited Panel
Section for Statistical Programmers and Analysts, Biopharmaceutical Section, Society for Clinical Trials
Organizer(s): Navneet Hakhu, University of California, Irvine
Chair(s): Navneet Hakhu, University of California, Irvine
10:05 AM Design and Evaluation of Adaptive Design Clinical Trials: Software Demonstration
Panelists: Scott Berry, Berry Consultants
Keaven Anderson, Merck & Co
Yannis Jemiai, Cytel Inc
Dan Gillen, University of California, Irvine
11:40 AM Floor Discussion
 
 

220186
Mon, 8/3/2020, 3:00 PM - 4:30 PM Virtual
Section of Statistical Programmers and Analysts - Open Invitation - All are welcome — Other Cmte/Business
Section for Statistical Programmers and Analysts
Chair(s): Vipin Arora, Eli Lilly and Company
Event: SSPA Open Mixer -All are Invited (SSPA Membership is not required)
AGENDA : Opening Remarks, Treasurer Report, Key Updates, Future activities, Q/A, wrap up
(Please share your questions in advance to Chair, Vipin Arora vipin.arora@gmail.com or Program Chair, Navneet Hakhu hakhunavneet@gmail.com or to our Treasurer, Gerald gerald.belton@gmail.com
 
 

224
Tue, 8/4/2020, 10:00 AM - 2:00 PM Virtual
Contributed Poster Presentations: Section for Statistical Programmers and Analysts — Contributed Poster Presentations
Section for Statistical Programmers and Analysts
1: Competing Risks Analysis for Cardiac Surgery Outcomes
Xiaoting Wu
2: Add Variability to Neural Networks
Sheng Yuan
3: Practical Guide of Multiple Imputation Method for Not Normally Distributed Data Using SAS
Anna Giczewska, Duke Clinical Research Institute
 
 

257 *
Tue, 8/4/2020, 1:00 PM - 2:50 PM Virtual
Online Experimentation at Scale: Challenges and Solutions — Invited Panel
Section on Statistical Learning and Data Science, Business and Economic Statistics Section, Section for Statistical Programmers and Analysts, Quality and Productivity Section
Organizer(s): Martin Tingley, Netflix
Chair(s): Iavor Bojinov, Harvard Business School
1:05 PM Online Experimentation at Scale: Challenges and Solutions
Panelists: Martin Tingley, Netflix
Somit Gupta, Microsoft
Xiaolin Shi, Snap
Myoungji Lee, Lyft
Guillaume Saint-Jacques, LinkedIN
Dennis Sun, Cal Poly and Google
2:40 PM Floor Discussion
 
 

314 * !
Wed, 8/5/2020, 10:00 AM - 11:50 PM Virtual
Statistical Advancements in Neurodegeneration Trial Designs and Analyses — Topic Contributed Papers
Section for Statistical Programmers and Analysts, Biopharmaceutical Section, Biometrics Section, Committee on Applied Statisticians
Organizer(s): Fanni Natanegara, Eli Lilly and Company
Chair(s): Fanni Natanegara, Eli Lilly and Company
10:05 AM Impact of Model Misspecification on Alzheimer Trial Operating Characteristics
Saptarshi Chatterjee, Eli Lilly and Co; Shrabanti Chowdhury, Icahn school of Medicine at Mount Sinai; Fanni Natanegara, Eli Lilly and Company
10:25 AM Multivariate Endpoint, Disease Progress Model and Other New Features of the DIAN-TU Platform Trial
Guoqiao Wang, Washington University in St Louis; Scott Berry, Berry Consultants; Chengjie Xiong, Washington University in St Louis; Jason Hassenstab, Washington University in St Louis; Melanie Quintana, Berry Consultants; Eric McDade, Washington University in St Louis; Paul Delmar, F. Hoffmann-La Roche Ltd; Matteo Vestrucci, University of Texas at Austin; Randall Bateman, Washington University in St Louis; Andrew Aschenbrenner, Washington University in St Louis
10:45 AM TRCPAD: Accelerating Participant Recruitment in Alzheimer’s Disease Clinical Trials Using Machine Learning Techniques
Oliver Langford, University of Southern California; Michael C Donohue, University of Southern California; Gustavo Jimenez-Maggiora, University of Southern California; Reisa Sperling, Harvard Medical School; Jeff Cummings, Cleveland Clinic Lou Ruvo Center for Brain Health; Paul S Aisen, University of Southern California; Rema C Raman, University of Southern California
11:05 AM Construction of Composite End Points to Better Align with Disease Progression and Improve Power
Samuel P Dickson, Pentara; Suzanne B Hendrix, Pentara; Newman Knowlton, Pentara; Noel Ellison, Pentara
11:25 AM Discussant: Richard Entsuah, Merck
11:45 AM Floor Discussion
 
 

412 * !
Wed, 8/5/2020, 1:00 PM - 2:50 PM Virtual
Incorporation of Real-World Evidence in Clinical Trial Designs and Associated Statistical Methodologies — Topic Contributed Papers
Section for Statistical Programmers and Analysts, Biopharmaceutical Section, Section on Statistical Learning and Data Science, Section on Statistical Computing
Organizer(s): Jeffrey Joseph, Covance; Swarna Reddy, Covance
Chair(s): Swarna Reddy, Covance
1:05 PM Using Real World Data to Evaluate the Generalizability of Evidence from Randomized Clinical Trials
Wei Shen, Eli Lilly and Company; Douglas Faries, Lilly Research Laboratories; Mark Belger, Eli Lilly and Company; Chen-Yen Lin, Eli Lilly and Company
1:25 PM Real World Evidence Use at CBER: Emerging Issues from Submissions
Jennifer Kirk, FDA, Center for Biologics Evaluation and Research (CBER)
1:45 PM Data Standardization to Facilitate Comparison of Real World Data and Clinical Trial Data
Aaron Galaznik, Acorn AI, a Medidata Company
2:05 PM Analytic Considerations for Constructing Real-World Control Arms
Katherine Tan, Flatiron Health; Brian Segal, Flatiron Health; Jonathan Bryan, Flatiron Health; Melissa Curtis, Flatiron Health; Nathan Nussbaum, Flatiron Health; Rebecca Miksad, Flatiron Health; Meghna Samant, Flatiron Health; Somnath Sarkar, Flatiron, Inc.; Aracelis Torres, Flatiron Health
2:25 PM Leverage Real World Evidence in Drug Development and Regulatory Decision Making
Rongmei Zhang, FDA, Center for Drug Evaluation and Research (CDER).
2:45 PM Floor Discussion
 
 

437
Thu, 8/6/2020, 10:00 AM - 11:50 AM Virtual
Complex Data Visualization: The Bright and Dark Side — Invited Panel
Section for Statistical Programmers and Analysts
Organizer(s): Vipin Arora, Eli Lilly and Company
Chair(s): Vipin Arora, Eli Lilly and Company
10:05 AM Complex Data Visualization: The Bright and Dark Side Presentation
Panelists: Simon Li, Pfizer Inc.
Natasa Rajicic, Cytel Inc
Melvin Munsaka, AbbVie
11:40 AM Floor Discussion